CN Stock MarketDetailed Quotes

Nanjing King-Friend Biochemical Pharmaceutical (603707)

Watchlist
  • 8.47
  • -0.06-0.70%
Trading May 20 09:45 CST
13.68BMarket Cap23.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing King-Friend Biochemical Pharmaceutical (603707) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Preparation3.52B88.10%
Standard heparin API400.73M10.04%
CDMO及其他68.61M1.72%
Other business5.55M0.14%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry3.99B99.86%
Other business5.55M0.14%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Abroad3.21B80.31%
Domestic780.09M19.55%
Other business5.55M0.14%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.32%
Sample Name
Sample Code
 +3.76%
Sample Name
Sample Code
 -2.17%
4
CHINA OILFIELD
02883
-2.18%
5
SHANGHAI PECHEM
00338
-2.38%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.02%
Sample Name
Sample Code
 +30.31%
Sample Name
Sample Code
 +28.56%
4
Emdoor Information
001314
+25.11%
5
Digital China Group
000034
+18.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -